Leads manufacturing cost accounting for BioMarin’s Technical Operations Finance team, overseeing inventory costing, standard costs, COGS, overhead absorption, excess and obsolescence, reconciliations, audits, SOX controls, and intercompany eliminations. Supports period close, financial reporting, ERP improvement projects, manufacturing variance analysis, and process improvements. Collaborates across Finance and Operations, manages compliance with US GAAP, and coaches junior staff.

Leads end-to-end global product supply planning for complex biopharmaceutical products across internal sites, CMOs/CDMOs, distribution partners, and markets. Develops supply, inventory, risk, contingency, and lifecycle strategies while balancing service, cost, capacity, and resilience. Owns Rough-Cut Capacity Planning governance across the 0–36 month IBP horizon, including process design, SAP IBP requirements, analytics, training, change management, and stakeholder alignment. Operates as an expert individual contributor through influence rather than direct authority.

Leads portfolio-level media strategy and execution for BioMarin’s U.S. Metabolic Conditions portfolio. Develops integrated HCP and patient media plans, manages agency partners and budgets, oversees activation and optimization, establishes measurement frameworks, and translates performance data into business recommendations. The role drives compliant, innovative, and measurable paid media across multiple rare disease brands while influencing senior stakeholders and coordinating Marketing, Analytics, Digital, Finance, Procurement, and Compliance teams.